Markets 1 sources

NRx Pharmaceuticals Reports Q2 Loss, Revenue Misses Expectations

Covered by 1 source · 1 article

BitcoinWorld NRx Pharmaceuticals Reports Q2 Loss, Revenue Misses Expectations NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported a loss for the second quarter of 2024, with revenue falling short of analyst expectations, according to the comp…

Covered by

Bitcoinworld

All coverage

NRx Pharmaceuticals Reports Q2 Loss, Revenue Misses Expectations

Bitcoin World 4h ago

NRx Pharmaceuticals Reports Q2 Loss, Revenue Misses Expectations